Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Avinger brings in $33mm through its Series D venture round

Executive Summary

Avinger Inc. (produces catheters for patients with peripheral artery disease) has raised $33mm through its Series D venture round. New backers contributed $11mm towards the financing. The company will use the proceeds to expand global sales of its current product lines and to plan clinical studies of upcoming cardiovascular devices. Avinger brought in $22.5mm through its Series C round earlier this year.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register